Research location
Nadiād
Gujarat, India
Advertisement
Research activity in Nadiād
Gujarat, IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 9 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Nadiād
9 linked trials · page 1 of 1Study of WAL0921 in Patients With Glomerular Kidney DiseasesNCT06466135 · 2024-07-02 · 1 site observation
RECRUITING
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)NCT05348876 · 2022-08-03 · 1 site observation
RECRUITING
A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 2 Diabetes MellitusNCT05705271 · 2023-02-08 · 1 site observation
COMPLETED
Indian Phenotype RegistryNCT03363594 · 2017-12-11 · 1 site observation
COMPLETED
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)NCT03071692 · 2017-03-23 · 1 site observation
TERMINATED
A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral PolyneuropathyNCT02107469 · 2014-06-01 · 1 site observation
COMPLETED
Ayurvedic Management of Chronic Kidney DiseaseNCT02477163 · 2014-01-01 · 1 site observation
COMPLETED
A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DMNCT01523405 · 2012-03-01 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate CancerNCT00626548 · 2008-01-01 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.